tirzepatide fda ruling Eli Lilly sues companies selling alternative versions of its weight loss drug Compounders protest as FDA removes

The FDA has issued warning letters to telehealth companies over misleading compounded GLP-1 marketing

If your body is dehydrated, your skin will look dull and your joints will feel stiff, regardless of how many supplements you take

Personalized treatment approaches The future of GLP-1 therapy is not about finding one best medication

Some patients also benefit from creatine supplementation, which has an excellent safety profile and supports muscle maintenance

The complaints also allege that the touted studies are on individual ingredients and do not actually measure the extracts together in a single supplement, so that "while they claim to have clinical support for the components of Lemme GLP-1 Daily, they did not study the combination of those extracts in a single supplementmeaning that the supplement has not been clinically tested." Many courts, including those in New York and California, preclude private individuals from challenging advertising based on the advertiser lacking adequate substantiation for their claims, as the plaintiffs have done in the Lemme complaints